Zota Healthcare Q2 FY27 Loss: Key Results Update

September-quarter result reported

Zota Health Care Ltd reported a consolidated net loss of ₹25.58 crore for the September quarter, according to the TradingView News headline provided. The result relates to the July-September period of FY27. The company’s board met on October 28, 2026, to consider and approve its standalone and consolidated unaudited financial results for the quarter and half year ended September 2026. The exchange announcement confirms that the board meeting considered the financial results. However, the supplied material does not provide a detailed consolidated profit and loss statement for the September quarter. It also does not specify consolidated revenue, expenses, EBITDA, margins, or earnings per share for the quarter. As a result, the reported net loss is the main September-quarter financial figure available in the source material.

Board meeting and exchange filing

Zota Health Care had informed the exchanges on October 22 that its board would meet on October 28 to approve Q2 FY27 standalone and consolidated results. On October 28, the company submitted the outcome of the board meeting along with unaudited standalone and consolidated financial results for the quarter and half year ended September 2026. The filing also referred to the relevant limited audit report. Such submissions are part of the listed company’s disclosure process. The supplied announcement does not include the numerical schedules attached to the financial results. Therefore, a direct comparison of the September-quarter loss with the immediately preceding quarter cannot be made from the available Q2 information alone. Investors will need the detailed filing for a fuller assessment of revenue, cost trends and balance-sheet movements.

Key figures available in the supplied data

The September-quarter loss of ₹25.58 crore is presented in a different context from the operating-revenue and net-loss figures shown in the supplied fundamentals. The source material associates the ₹173.60 crore revenue number with the June 2026 quarter in other references. It should not therefore be treated as confirmed September-quarter revenue. All revenue values in this report are expressed in crore rupees.

June-quarter financial context

The most recent detailed quarterly information in the supplied material relates to Q1 FY27, ended June 2026. Zota Health Care reported revenue of ₹173.60 crore for that quarter, with revenue growth of about 67% year on year in the provided references. Another supplied result summary placed total income for the June quarter at ₹175.65 crore. These are different measures and should not be used interchangeably. The company recorded a net loss of ₹43.94 crore in the June quarter, while the fundamentals section lists a quarterly loss of ₹43.56 crore. The source also said the June-quarter loss was higher than the ₹13.78 crore loss reported in Q1 FY26. Employee cost of ₹61.12 crore and depreciation of ₹27.75 crore were cited as factors affecting that period’s result.

Davaindia store network expanded

Store expansion remained an important operating development during the September quarter. Zota Health Care reported that the Davaindia network had 2,840 operative stores as of September 30, 2026. During Q2 FY27, it opened 20 stores, comprising four company-owned, company-operated stores and 16 franchise-owned, franchise-operated stores. Five franchise-operated outlets closed during the period. This resulted in a net addition of 15 stores from 2,825 at June 30, 2026. The supplied data identified Davaindia as the retail segment that contributed 83% of total sales in the June quarter. The store count update provides operational context but does not establish the revenue contribution of the additional Q2 outlets.

Expansion pace moderated in Q2

The supplied material described a moderate pace of store expansion in Q2 FY27 and a focus on sustainable growth. This followed a stronger expansion phase in the June quarter, when the company was reported to have opened 264 new stores on a gross basis and added 246 stores on a net basis. The difference between the two quarters is notable. Q2 added 15 net stores, compared with the larger net increase cited for Q1. The information does not state why the pace changed. It would therefore be inappropriate to attribute the moderation to funding, demand, profitability, or any other specific factor. Still, the store update shows that the company continued to add outlets while recording some closures.

What the loss means for investors

The reported consolidated loss of ₹25.58 crore keeps attention on Zota Health Care’s path toward operating and cash break-even. The source material had previously stated a target of cash break-even in Q1 FY28 and indicated that EBITDA was expected to turn positive in the next quarter. Those statements were presented as management targets or expectations in the supplied Q1-related material, not as achieved results. The September-quarter headline alone does not confirm whether the EBITDA expectation was met. It also does not provide enough detail to assess changes in gross margin, employee expenses, depreciation, marketing spending, or finance costs. Investors will need to separate verified reported figures from company targets when reviewing the results.

Revenue data requires careful reading

A separate supplied item described Q1 FY27 revenue as ₹17,360 lakh. Converted to a common unit, that equals ₹173.60 crore. The same item incorrectly displayed the amount as ₹17,360 crore in places, which conflicts with its own lakh-based figure and with the ₹173.60 crore quarterly revenue stated elsewhere. The consistent revenue figure available for the June quarter is ₹173.60 crore. There is no confirmed September-quarter revenue figure in the supplied information. This distinction matters because revenue is required to evaluate whether a net loss reflects higher costs, lower margins, slower sales, or a combination of factors. Without the detailed Q2 statement, those conclusions cannot be supported.

Earnings call scheduled after results

Zota Health Care had said it would announce Q2 FY27 results on October 28, 2026, and host an earnings call on October 29 at 12:00 IST. The call is the next identified forum in the supplied information where management may discuss quarterly performance and operating developments. The company’s earlier filings also referenced an audio recording of its August earnings call on the June-quarter results. For the September quarter, the detailed results release and management commentary will be important for clarifying the financial drivers behind the reported consolidated loss. Particular areas to monitor include revenue disclosure, operating costs, store productivity, depreciation and management’s comments on break-even targets.

Market impact and conclusion

The September-quarter update places Zota Health Care’s financial performance alongside continued, though slower, Davaindia network expansion. The reported consolidated loss of ₹25.58 crore is the principal confirmed Q2 FY27 financial figure in the supplied material. By contrast, the ₹173.60 crore revenue figure belongs to the June-quarter context and should not be read as September-quarter revenue. The company ended September with 2,840 operative Davaindia stores after a net addition of 15 outlets in the quarter. The October 29 earnings call and the detailed exchange filing are the next available reference points for investors seeking a complete view of the Q2 FY27 result.